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Background: Acute gastroenteritis (AGE) remains a common cause of clinic visits and hospitalizations, though its
aetiology has not been determined in Qatar.
Methods: We performed a prospective, emergency department–based study of 288 children and adults with AGE.
Stool specimens were collected at presentation from June to November 2009. Faecal specimens were tested, using
real-time PCR, for a panel of four viral (norovirus, adenovirus, astrovirus and rotavirus) and bacterial pathogens.
Results: Viral and bacterial pathogens were detected in 131 (45.5%) and 34 (12.2%) of the 288 patients recruited.
The most commonly detected pathogens were norovirus (28.5%), rotavirus (10.4%), followed by adenovirus (6.25%)
and astrovirus (0.30%). Norovirus was the most commonly detected viral pathogen amongst all the age groups
with an almost even distribution in all age groups. Rotavirus and adenovirus were more common in children under
5 yr of age. Astrovirus was found in only one person.
Conclusions: Viruses, especially noroviruses, are associated with severe diarrhoea in children and adults in Qatar.
Further studies to confirm the findings and to explore the causes of illness among patients from whom a pathogen
cannot be determined are needed.
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Acute gastroenteritis (AGE) is a common cause for hos-
pital/clinic visits and hospitalisations in children as well
as adults [1,2]. It is characterised by diarrhoea, vomiting
and abdominal pain that may lead to hypovolemic shock
and dehydration, and subsequently death in severe cases.
Children in developing countries are particularly at risk
of both morbidity and mortality [1]. Worldwide, gastro-
enteritis affects 3 to 5 billion children each year, and ac-
counts for 1.5 to 2.5 million deaths per year or 12% of
all deaths among children less than 5 years of age [1]. In
developed countries AGE accounts for 300 deaths per
year [1].
Among adults, an estimated 179 million cases of AGE
occur each year, resulting in millions of clinic visits,
nearly 500,000 hospitalisations, and >5000 deaths [2].* Correspondence: aaja@qu.edu.qa
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reproduction in any medium, provided the orAlthough the burden of AGE in children has been de-
scribed extensively, there is little data on AGE in adults.
Four major viral pathogens have been associated with
AGE. These include three RNA viruses (rotavirus, noro-
virus, and astrovirus) and one DNA virus (enteric adeno-
virus) [3,4]. Saporovirus, Aichivirus and members of
enterovirus group also cause AGE but are less common [5].
Noroviruses are now recognised as the leading cause
of epidemic gastroenteritis in all age groups, accounting
for over 90% of viral gastroenteritis outbreaks and ap-
proximately 50% of all gastroenteritis outbreaks [6]. Past
reviews have shown that norovirus was responsible for
4.4%–8.7% of AGE cases among adults and elderly indi-
viduals admitted to the emergency department (ED) or
hospitalized [7]. In Bangladesh, it is estimated that
200,000 deaths are caused by norovirus gastroenteritis
annually though more data on viral aetiology in AGE in
developing countries is sparse [8]. Rotavirus is the most
common cause of severe childhood diarrhoea worldwidel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the basis of antigenic variations. Each year worldwide,
rotavirus causes approximately 111 million episodes of
gastroenteritis requiring only home care, 25 million of-
fice visits, and 2 million hospitalizations [10]. Enteric ad-
enoviruses can also cause AGE. The prevalence rate of
adenovirus gastroenteritis is not as high as rotavirus or
norovirus infections, however it is still very important to
monitor these infections for epidemiologic and surveil-
lance studies. Enteric adenovirus have been related to
AGE in variable frequency (ranging from 1.4 to 10%),
depending on the geographic settings [11,12]. Astrovirus
has also been associated with AGE, with a frequency
range between 2% to 26% [13]. However, there is a pau-
city of data on viral aetiology in AGE in the Middle East
both in adult and in paediatric population. Indeed, in
Qatar there has not been any study investigating viral
aetiology of AGE to date.
This study prospectively enrolled and tested children
and adults with AGE presenting to our hospital to deter-
mine the frequency and aetiology of viral infectious
AGE, using real-time reverse transcription (RT)-PCR
and primers for adenovirus, astrovirus, enterovirus, and
rotavirus. To our knowledge, no study has reported
complete information regarding the number and distri-
bution of these four viruses responsible for gastroenter-
itis in hospitalised patients (children and adults) in
Qatar specifically or in the Middle East in general.
Methods
Patients
Patients who visited the hospital at Hamad Medical Cor-
poration (HMC), Qatar with AGE-like complaints were
enrolled in the study; they were aged 1 month to 84 yr
old. Demographic information and clinical history was
collected for all the patients. A total of 288 patients were
enrolled in the study. The patients were enrolled in the
study between June 2009 and November 2009.
Patients who visited the hospital with complaints of
AGE were enrolled in the study after excluding those
with bloody and formed stools. AGE was defined as ≥1
episode diarrhoea with abdominal discomfort with 24
hour period and passing of loose/watery/soft stool.
All enrolled patients/their guardians, in case of chil-
dren gave written informed consent. The study was ap-
proved by the ethical board at Hamad Medical Research
Center.
Stool samples collection and pre-treatment
Stool samples were collected from each subject during
the hospital visit within 24 hours. The samples were
obtained only once from each patient. A total of 288
samples were collected (one sample per patient) and fro-
zen at −86°C. The frozen samples were transported toQatar University Health Science Department research la-
boratory for analysis.
One hundred milligram (100 mg) of solid or liquid
stool was re-suspended in 900 μl Buffer ASL (Stool Lysis
Buffer). Each sample was then vortexed vigorously for 1
minute. Samples were then incubated for 10 minutes at
room temperature to allow sedimentation of large stool
particles. Approximately 500 μl supernatant was trans-
ferred from the top of the suspension to a fresh screw
cap tube without carryover of large stool particles. Fi-
nally, samples were incubated for 10 minutes at 70°C in
a thermoshaker.
Extraction of viral RNA
Pre-treated samples were placed into an extraction in-
strument, The EZ1 Mini. The manufacturer’s instruc-
tions were followed to extract viral RNA (QIAGEN
QIAamp Viral RNA Mini Kits EZ1 Virus Mini Kit v2.0,
catalog number 955134, Germany).
Viruses
Amplification and detection of the four viruses
(norovirus, adenovirus, rotavirus and astrovirus) was
performed by a two tube multiplex PCR assay (Fast
Track Diagnostics, Luxemburg) using an ABI 7500 Real
Time PCR instrument, according to the manufacturer’s
instructions.
Bacteria
A swab of each stool specimen was examined for bac-
teria, including Salmonella spp., Shigella spp., E. coli spp,
and Campylobacter spp using routine diagnostic assays.
Statistical analysis
Prevalence rates were expressed as percentages. No stat-
istical analyses were performed for this study.
Results
Patients
During the study period, 288 subjects were enrolled. Pa-
tient demographics are summarised in Table 1.
All the patients were Qatar residents at time of the
study, though not all were Qatari nationals.
Aetiology from the stool samples
All the subjects provided stool specimens. A total of 288
stool samples were analysed, and viral agents were iden-
tified in 131 patients (45.5%), followed by bacterial infec-
tions (n = 34; 12.2%).
Table 2 summarises the sample numbers which tested
positive for virus types by month of study. The highest
number of infections was detected in July and September
(the warm season in Qatar).
Table 1 Patient characteristics
Characteristic Value (n = 288)
Age, years 16.6 (≤1 -84)
Median (range) 38 (13.2%)
<1 83 (29%)
1-10 29 (10.1%)
11-20 75 (26%)
21-50 24 (8.3%)
51-60 29 (10.1%)
>60 10 (3.5%)
Unspecified age
Gender
Male 153 (53.1%)
Female 129 (44.8%)
Sex not recorded 6 (2.1%)
Chronic diseases Total = 27 (9.4%)
Cardiovascular disease (CVD) 2
Acute renal failure 1
Renal disease 8
Anaemia 11
Lymphoma/Leukemia 2
Liver disease 2
Irritable bowel syndrome 1
Table 3 Viral aetiology distribution by patient age
Age (yr) Norovirus
(N = 82)
Rotavirus
(N = 30)
Adenovirus
(N = 18)
Astrovirus
(N = 1)
<1 10 (12.2%) 11 (36.7%) 3 (16.7%) 0
N = 38
1-10 17 (20.7%) 10 (33.3%) 8 (44.4%) 0
N = 83
11-20 9 (11.0%) 0 2 (11.1%) 1 (100%)
N = 29
21-50 29 (35.4%) 5 (16.7%) 2 (11.1%) 0
N = 75
51-60 7 (8.5%) 4 (13.3%) 0 0
N = 24
>60 10 (12.2%) 0 3 (16.7%) 0
N = 29
Unspecified age 0 0 0 0
N = 10
Total 82 (28.4%) 30 (10.4%) 18 (6.25) 1 (0.30%)
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imens (82 of 288); rotavirus was detected in 10.4% (30 of
288); adenovirus was detected in 6.25% (18 out of 288);
and astrovirus was detected in 0.30% (1 out of 288). No
patients were co-infected with more than one virus.
Norovirus was the predominant viral agent identified in
this study.
Salmonella was the most common bacterial species
detected (n = 23), followed by E. Coli (n = 6); Shigella
(n = 3); and Campylobacter (n = 3).
Epidemiologic features
The distribution of patients according to age is shown in
Table 3.Table 2 Samples tested positive for viruses by month
Month Viruses N (%)
Norovirus Rotavirus Adenovirus Astrovirus
N = 281* N = 82 N = 30 N = 18 N = 1
June (n = 37) 10 (27%) 8 (22%) 2 (5%) 0
July (n = 99) 32 (32%) 11 (11%) 8 (8%) 1 (1%)
August (n = 32) 15 (47%) 1 (3%) 1 (3%) 0
September (n = 72) 16 (22%) 10 (14%) 5 (7%) 0
October (n = 41) 9 (22%) 0 2 (5%) 0
*Seven samples were excluded due to poor sample quality or due to not
obtaining enough samples to analyse.Norovirus was the most commonly detected viral
pathogen amongst all the age groups with an almost
even distribution in all age groups. Rotavirus and adeno-
virus were more common in children under 5 yr. How-
ever, the numbers were too small to make definitive
conclusions. Astrovirus was found in only one person.
Discussion
This study provides novel data on the infectious causes
of AGE in children and adults in Qatar. A viral agent
was identified in almost 50% of the patients (131/288).
No correlations of symptom severity and viral aetiology
were made in this study. The causes of these diseases (e.
g. recent travel, food, etc.) were not investigated. Al-
though the highest rate of infection was observed in July
and September, which constitute the warm season in
Qatar, it is difficult to make accurate conclusions re sea-
sonality due to the low number of the samples; the fact
that the samples were tested only once during the 6
month study period and the differences could be
explained by the higher number of subjects recruited
during those two months (Table 2).
Norovirus was the most frequently identified cause of
hospital visits for AGE, with detection in 28.4% and an
almost even distribution across all age groups. This cor-
relates well with a study of AGE in adults by Bresee
et al., who also found norovirus to be the most common
aetiologic agent for AGE (detected in 27% of patients
with a median age of 31 yr) [2]. Furthermore, other stud-
ies on adults in industrialised countries have also identi-
fied norovirus as the leading cause of AGE – infecting
30% of adults in England [14-16]. Noroviruses has been
detected in 16% of cases and 3% of controls in
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However, other studies have found a prevalence ≤10%
for norovirus in AGE [17-19]. The higher prevalence in
our study may reflect a higher rate of infection with
norovirus in Qatar though larger studies may be re-
quired to corroborate this finding.
Rotavirus was found in 10.4% of subjects, mostly chil-
dren less than 5 years of age. This is consistent with pre-
vious studies which have shown that rotaviruses are the
most common cause of severe gastroenteritis among
young children, but adult cases are thought to be un-
common [20-22]. The nine cases of rotavirus infection
in adults may reflect the lack of rotavirus children’s im-
munisation programme in Qatar until very recently
(March 2009). The vaccine is now offered to all children
less than 2 years of age, therefore, many patients would
not have been immunised when this study was under-
taken. Rotavirus vaccine may also confer protection in
parents of vaccinated children [23]. Thus, conducting
such a study in the rotavirus vaccine era is a limitation
in itself.
Salmonella and E. Coli species were the most common
bacterial pathogens identified. However, antiobiotic use
was not monitored in this study therefore it is difficult
to comment on these findings.
This study has several limitations. This study did not
take into account correlation of clinical symptoms or
duration of illness with viral aetiology. Therefore, we
cannot ascertain variables that would help clinicians tar-
get specific patients for testing. Furthermore, our sam-
ples were collected from June 2009 to November 2009,
which are mostly the summer months in Qatar and
many residents travel to various countries and may carry
viruses back with them though no data had been col-
lected to assess patients for recent international travel;
therefore, the contribution of this factor to viral aeti-
ology is not known. In addition, we investigated only
one strain of adenovirus, astrovirus and rotavirus; and
two strains of norovirus. All common strains of these vi-
ruses should be investigated in future studies. Moreover,
only patients presenting to a hospital were included in
this study. In order to investigate the true burden of
viral gastroenteritis, community-based studies are neces-
sary. Finally, the lack of healthy controls limits conclu-
sions about the relative importance of each pathogen.
Despite these limitations, this study provides the most
comprehensive data to date on the aetiology of AGE in
patients in Qatar.
This study indicated that the two most common
gastroenteritis viruses in Qatar are the norovirus and
rotavirus. Nevertheless, large scale controlled studies are
necessary to fully understand the aetiology and burden
of viral pathogens in AGE in Qatar. Future studies
should be carried out in samples collected throughoutthe year to assess the impact of winter vs. summer infec-
tions and international travel. Correlations of viruses
with clinical symptoms and symptom severity also need
to be performed.
Conclusion
The epidemiologic surveillance of enteric viruses is a key
step in understanding the burden of these infections in
human health and their impact on the national health
costs in Qatar. To date, no data on viral epidemiologic
surveillance of AGE have been published in Qatar. The
high prevalence of viral agents found in this study may
have important implications for testing patients with
AGE and minimizing use of antibiotics. The aim of con-
trol and prevention plans for viral gastroenteritis is to
minimise nosocomial infections, to limit unnecessary
antibiotic treatment, and ultimately to help develop a
vaccination/immunisation campaign at the national
level, if necessary, which are all significant improvements
to the health system needed in Qatar.
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